Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes

Kommoss, Stefan; Winterhoff, Boris; Oberg, Ann L.; Konecny, Gottfried E.; Wang, Chen; Riska, Shaun M.; Fan, Jian-Bing; Maurer, Matthew J.; April, Craig; Shridhar, Viji; Kommoss, Friedrich; du Bois, Andreas; Hilpert, Felix; Mahner, Sven; Baumann, Klaus; Schroeder, Willibald; Burges, Alexander; Canzler, Ulrich; Chien, Jeremy; Embleton, Andrew C.; Parmar, Mahesh; Kaplan, Richard; Perren, Timothy; Hartmann, Lynn C.; Goode, Ellen L.; Dowdy, Sean C.; Pfisterer, Jacobus

Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes

Author:

Kommoss, Stefan; Winterhoff, Boris; Oberg, Ann L.; Konecny, Gottfried E.; Wang, Chen; Riska, Shaun M.; Fan, Jian-Bing; Maurer, Matthew J.; April, Craig; Shridhar, Viji; Kommoss, Friedrich; du Bois, Andreas; Hilpert, Felix; Mahner, Sven; Baumann, Klaus; Schroeder, Willibald; Burges, Alexander; Canzler, Ulrich; Chien, Jeremy; Embleton, Andrew C.; Parmar, Mahesh; Kaplan, Richard; Perren, Timothy; Hartmann, Lynn C.; Goode, Ellen L.; Dowdy, Sean C.; Pfisterer, Jacobus

Tübinger Autor(en):

Kommoss, Stefan

Published in:

Clinical Cancer Research (2017), Bd. 23, H. 14, S. 3794-3801

Verlagsangabe:

Amer Assoc Cancer Research

Language:

English

Full text:

http://dx.doi.org/10.1158/1078-0432.CCR-16-2196

ISSN:

1557-3265